Tenet Healthcare Is Maintained at Buy by Truist Securities
Truist Financial Maintains Tenet Healthcare(THC.US) With Buy Rating, Announces Target Price $180
Tenet Healthcare Analyst Ratings
Tenet Healthcare Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on Tenet Healthcare, Maintains $168 Price Target
Wells Fargo Maintains Tenet Healthcare(THC.US) With Buy Rating, Maintains Target Price $175
Barclays Maintains Tenet Healthcare(THC.US) With Buy Rating, Maintains Target Price $171
Barclays Keeps Their Buy Rating on Tenet Healthcare (THC)
BofA Securities Maintains Tenet Healthcare(THC.US) With Buy Rating
Bank of America Securities Sticks to Their Buy Rating for Tenet Healthcare (THC)
Cantor Fitzgerald Reiterates Overweight on Tenet Healthcare, Maintains $168 Price Target
Tenet Healthcare Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on Tenet Healthcare, Maintains $168 Price Target
Tenet Healthcare Analyst Ratings
UBS Maintains Buy on Tenet Healthcare, Raises Price Target to $197
J.P. Morgan Sticks to Its Buy Rating for Tenet Healthcare (THC)
Jefferies Maintains Tenet Healthcare(THC.US) With Buy Rating, Raises Target Price to $175
Truist Financial Remains a Buy on Tenet Healthcare (THC)
Truist Financial Maintains Tenet Healthcare(THC.US) With Buy Rating
Wells Fargo Maintains Tenet Healthcare(THC.US) With Buy Rating, Maintains Target Price $175